Combination amsacrine and high-dose cytosine arabinoside in acute leukemia

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Leukemia & lymphoma·2016

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Leukemia & lymphoma·2016

Current status of mitoxantrone combination chemotherapy programs: a personal view.

Leukemia & lymphoma·2010

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia.

Leukemia·1996

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.

Acta haematologica·1994

A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.

Seminars in oncology·1992

Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Purple Blossoms.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Novel Levoglucosenone Derivatives: Preclinical Evaluation in Breast Cancer Models.

European journal of pharmacology·2026

Galectin-3 and its inhibitors: Overview and perspectives.

Pharmacology & therapeutics·2026

Synthetically accessible naphthalene-based rigid-core electrolytes as membrane-active antibacterial agents against drug-resistant pathogens.

European journal of medicinal chemistry·2026

Extraction method, structure-activity relationship and anti-tumor mechanism of Lycium barbarum polysaccharides.

RSC advances·2026

Development and In Vitro Efficacy of Macrophage-Targeted Nanoparticles Encapsulating Vitamin E Derivatives Garcinoic Acid and α‑13'-Carboxychromanol.

ACS omega·2026

Development and In Vitro/In Vivo Characterization of Surface-Modified Nintedanib-Loaded Nanoparticles for Enhanced Bioavailability in Chronic Kidney Disease.

ACS omega·2026

Related Experiment Videos

Combination amsacrine and high-dose cytosine arabinoside in acute leukemia

Related Concept Videos

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Current status of mitoxantrone combination chemotherapy programs: a personal view.

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia.

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.

A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.

Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.

Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.

Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

Purple Blossoms.

Novel Levoglucosenone Derivatives: Preclinical Evaluation in Breast Cancer Models.

Galectin-3 and its inhibitors: Overview and perspectives.

Synthetically accessible naphthalene-based rigid-core electrolytes as membrane-active antibacterial agents against drug-resistant pathogens.

Extraction method, structure-activity relationship and anti-tumor mechanism of Lycium barbarum polysaccharides.

Development and In Vitro Efficacy of Macrophage-Targeted Nanoparticles Encapsulating Vitamin E Derivatives Garcinoic Acid and α‑13'-Carboxychromanol.

Development and In Vitro/In Vivo Characterization of Surface-Modified Nintedanib-Loaded Nanoparticles for Enhanced Bioavailability in Chronic Kidney Disease.

Related Experiment Videos

Combination amsacrine and high-dose cytosine arabinoside in acute leukemia

Related Concept Videos

Related Articles